Correlation Between Aquestive Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Aquestive Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Aquestive Therapeutics and Entero Therapeutics,
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aquestive and Entero is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 0.51 times more return on investment than Entero Therapeutics,. However, Aquestive Therapeutics is 1.94 times less risky than Entero Therapeutics,. It trades about 0.09 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 94.00 in Aquestive Therapeutics on August 30, 2024 and sell it today you would earn a total of 422.00 from holding Aquestive Therapeutics or generate 448.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Entero Therapeutics,
Performance |
| Timeline |
| Aquestive Therapeutics |
| Entero Therapeutics, |
Aquestive Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Aquestive Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Aquestive Therapeutics vs. Emergent Biosolutions | Aquestive Therapeutics vs. Bausch Health Companies | Aquestive Therapeutics vs. Neurocrine Biosciences | Aquestive Therapeutics vs. Teva Pharma Industries |
| Entero Therapeutics, vs. Unilever PLC ADR | Entero Therapeutics, vs. American Axle Manufacturing | Entero Therapeutics, vs. PACCAR Inc | Entero Therapeutics, vs. Weyco Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |